Christian will play an active role in supporting the continued growth of QuTEM and S4DX, two of Katalysen’s core portfolio companies in the life sciences sector. Through his extensive international network and experience in commercial transformation, Christian will help further accelerate their strategic development and explore potential synergies between his and Katalysen’s ecosystems.

“Christian’s background and perspective will add real value to both QuTEM and S4DX,” comments Katalysen Chairman Peter Almberg. “Few people combine such deep operational experience with a truly global view of healthcare markets.”

Christian’s career includes senior executive positions at some of the world’s leading healthcare companies, including MSD (Merck), Pfizer, and Abbott Laboratories. He has served as SVP and Head of Strategy for Emerging Markets at MSD, CEO for Pfizer in Russia and CIS, and Head of International Marketing at Abbott Diagnostics, overseeing operations across Asia, Latin America, Eastern Europe, and the Middle East. Throughout his career, he has managed P&Ls exceeding $1.8 billion and led teams of more than 3,000 employees.